NCT01044745 2023-09-06Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic CancerUniversity of NebraskaPhase 2 Terminated20 enrolled 8 charts
NCT02877082 2018-04-30Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant PatientsEmory UniversityPhase 2 Terminated5 enrolled 10 charts
NCT00617929 2017-12-28Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantMasonic Cancer Center, University of MinnesotaPhase 2 Terminated12 enrolled 12 charts